908 Devices

MASS · NASDAQ

$11.51+$0.08 (+0.70%)TodayMarket closed ·
Prev close $11.43

About MASS

908 Devices, Inc. engages in the development of measurement devices for chemical and biochemical analysis. The company is headquartered in Burlington, Massachusetts and currently employs 172 full-time employees. The company went IPO on 2020-12-18. The firm's device offerings include MX908, XplorIR, ThreatID, ProtectIR, VipIR, and AVCAD components. MX908 is a handheld, battery-powered, Mass Spec device designed for the analysis of solid, liquid, vapor and aerosol materials of unknown identity. The company is a multipurpose device utilized by a spectrum of user segments for a variety of field applications, including chemical, explosive, priority drug and HazMat operations, detecting materials at the trace level. XplorIR is a handheld device that uses FTIR spectroscopy to identify, quantify and track gases and vapors. ThreatID is a portable FTIR device that rapidly detects and identifies 28,000+ unknown gas, vapor, powder and liquid chemical hazards.

Employees
172
Headquarters
Burlington, Massachusetts
Listed
Dec 18, 2020
Sector
Information Technology
Industry
Electronic Equipment, Instruments & Components

MASS key statistics

Market cap
472.44M
Price-earnings ratio
0.00
Dividend yield
—
Average volume
380.18K
Volume
276.73K
Open price
$11.38
High today
$11.86
Low today
$11.18
52 Week high
$13.35
52 Week low
$5.03

908 Devices (MASS) at a glance

As of Oct 20, 2026, 908 Devices (MASS) shares are priced at $11.51, giving the company a market cap of 472.44M and a price-to-earnings ratio of 0.00.

Today the stock has traded between $11.18 and $11.86. The current price is 3.0% above the day's low and 3.0% below its high.

Volume so far is 276.73K shares, below the average of 380.18K shares a day.

Over the past year 908 Devices has ranged from $5.03 to $13.35, and now sits 78% of the way up that range.

908 Devices met or beat analyst EPS estimates in 4 of the last 8 quarters. In Q2 FY26 it reported -$0.32 per share against an estimate of -$0.1734.

The average analyst price target is $13.64, 18.5% above the current price, from 3 recent ratings.

Analyst ratings

Latest rating from each analyst over the past 12 months

100%of 3 analyst ratings say Buy
  • Buy100.0%
  • Hold0.0%
  • Sell0.0%
Price target · 6 analystsAvg $13.64
Low
$12.12
Now
$11.51
High
$14.70

MASS earnings

Earnings per share, reported against the analyst estimate

Beat the estimate in 4 of the last 8 quarters, by 93.3% on average.

  1. Q3 FY24: reported $0.04 per share against an estimate of -$0.2881
  2. Q4 FY24: reported -$0.56 per share against an estimate of -$0.3529
  3. Q1 FY25: reported -$0.28 per share against an estimate of -$0.3315
  4. Q2 FY25: reported -$0.18 per share against an estimate of -$0.187
  5. Q3 FY25: reported -$0.41 per share against an estimate of -$0.1734
  6. Q4 FY25: reported $0.10 per share against an estimate of -$0.0714
  7. Q1 FY26: reported -$0.32 per share against an estimate of -$0.1598
  8. Q2 FY26: reported -$0.32 per share against an estimate of -$0.1734

MASS news

  • Press releaseBusiness Wire

    908 Devices to Present at the 32nd Annual Gabelli Aerospace & Defense Symposium

  • Press releaseBusiness Wire

    908 Devices to Present at the 17th Annual Midwest IDEAS Investor Conference

  • 12 Information Technology Stocks Moving In Tuesday's Intraday Session

  • Press releaseBusiness Wire

    908 Devices Reports Second Quarter 2026 Financial Results and Raises Low End of 2026 Revenue Outlook

  • Press releaseBusiness Wire

    908 Devices to Participate in the Canaccord Genuity 46th Annual Growth Conference

  • Press releaseBusiness Wire

    908 Devices to Report Second Quarter 2026 Financial Results on August 11, 2026

  • Press releaseBusiness Wire

    908 Devices Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

  • Press releaseBusiness Wire

    908 Devices to Present at the 16th Annual East Coast IDEAS Investor Conference

Similar companies

Companies in the same industry as 908 Devices

Most active stocks

Highest trading volume today

Newly listed

Companies that went public in the past six weeks

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.